• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemics. Towards measles elimination in Italy: monitoring herd immunity by Bayesian mixture modelling of serological data

Giuseppe

Emeritus
[Source: Epidemics, full text: (LINK). Abstract, edited.]

Towards measles elimination in Italy: monitoring herd immunity by Bayesian mixture modelling of serological data

Publication year: 2012

Source: Epidemics

Del Fava Emanuele, Shkedy Ziv, Angela Bechini, Paolo Bonanni, Piero Manfredi


The analysis of post-vaccination serological data poses nontrivial issues to the epidemiologists and policy makers who want to assess the effects of immunisation programs. This is especially true for infections on the path to elimination as is the case for measles. We address these problems by using Bayesian normal mixture models fitted to antibody counts data. This methodology allows us to estimate the seroprevalence of measles by age and, in contrast to conventional methods based on fixed cut-off points, to also distinguish between groups of individuals with different degrees of immunisation. We applied our methodology to two serological samples collected in Tuscany (Italy) in 2003 and in 2005?2006 respectively, i.e., before and after a large vaccination campaign targeted to school-age children. Besides showing the impact of the campaign, we were able to accurately identify a large pocket of susceptible individuals aged about 13-14 in 2005?2006, and a larger group of weakly immune individuals aged about 20 in 2005?2006. These cohorts therefore represent possible targets for further interventions towards measles elimination.
-
------
 
Back
Top Bottom